Showing results (81-90 of 87) with videos related to
Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 87 results.
Nature Communications|February 4, 2026
Indolent primary cutaneous B-cell lymphomas resemble persistent antigen reactions without signs of dedifferentiationJohannes Griss, Sabina Gansberger, Inigo Oyarzun, et al.Experimental Dermatology|June 16, 2016
Efficacy and safety of ustekinumab treatment in adults with moderate-to-severe atopic dermatitisSaakshi Khattri, Patrick M Brunner, Sandra Garcet, et al.Journal of the American Academy of Dermatology|January 22, 2018
Efficacy and safety of fezakinumab (an IL-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional treatments: A randomized, double-blind, phase 2a trialEmma Guttman-Yassky, Patrick M Brunner, Avidan U Neumann, et al.The Journal of Allergy and Clinical Immunology|September 28, 2016
Early-onset pediatric atopic dermatitis is TH2 but also TH17 polarized in skinHitokazu Esaki, Patrick M Brunner, Yael Renert-Yuval, et al.The Journal of Allergy and Clinical Immunology|August 20, 2018
Baseline IL-22 expression in patients with atopic dermatitis stratifies tissue responses to fezakinumabPatrick M Brunner, Ana B Pavel, Saakshi Khattri, et al.Allergo Journal International|June 28, 2021
Immunologically relevant aspects of the new COVID-19 vaccines-an ÖGAI (Austrian Society for Allergology and Immunology) and AeDA (German Society for Applied Allergology) position paperEva Untersmayr, Elisabeth Förster-Waldl, Michael Bonelli, et al.Nature Immunology|November 18, 2024
Cutaneous T cell lymphoma atlas reveals malignant TH2 cells supported by a B cell-rich tumor microenvironmentRuoyan Li, Johanna Strobl, Elizabeth F M Poyner, et al.Pageof 9